SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 75 filers reported holding SEELOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $24,023 | +70.1% | 20,103 | -1.6% | 0.00% | – |
Q1 2023 | $14,127 | -1.4% | 20,438 | -3.1% | 0.00% | – |
Q4 2022 | $14,322 | -42.7% | 21,093 | -12.1% | 0.00% | – |
Q3 2022 | $25,000 | -75.7% | 24,003 | -84.1% | 0.00% | – |
Q2 2022 | $103,000 | -6.4% | 151,335 | +15.0% | 0.00% | – |
Q1 2022 | $110,000 | -56.9% | 131,609 | -16.1% | 0.00% | – |
Q4 2021 | $255,000 | +8.5% | 156,833 | +60.6% | 0.00% | – |
Q3 2021 | $235,000 | -48.1% | 97,645 | -43.1% | 0.00% | – |
Q2 2021 | $453,000 | -58.5% | 171,595 | -21.5% | 0.00% | – |
Q1 2021 | $1,091,000 | +1002.0% | 218,611 | +250.1% | 0.00% | – |
Q4 2020 | $99,000 | – | 62,441 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |